Flow cytometry analysis demonstrated increased infiltration of CD4+ T cells, CD8+ T cells, and NK cells in the tumor tissues of the mCGYL-LOx treatment group, accompanied by a significant reduction in Tregs. The gene discussed is CD8A; the disease is neoplasm.